<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>112th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>S. 2321</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20120419">April 19, 2012</action-date>
			<action-desc><sponsor name-id="S306">Mr. Menendez</sponsor> (for
			 himself and <cosponsor name-id="S213">Mr. Akaka</cosponsor>) introduced the
			 following bill; which was read twice and referred to the
			 <committee-name committee-id="SSHR00">Committee on Health, Education, Labor,
			 and Pensions</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Public Health Service Act to provide for the
		  expansion, intensification, and coordination of the programs and activities of
		  the National Institutes of Health with respect to Tourette
		  syndrome.</official-title>
	</form>
	<legis-body id="H5D29CD88FD6F4AB89103082F07589B2E" style="OLC">
		<section id="H597E0AFEFD8F44AE89D394F7FE9535B5" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Collaborative Academic Research
			 Efforts for Tourette Syndrome Act of 2012</short-title></quote>.</text>
		</section><section id="HB055F7E75F184509AD94A82E3444072B"><enum>2.</enum><header>Programs of the
			 National Institutes of Health relating to Tourette syndrome</header><text display-inline="no-display-inline">Part B of title IV of the Public Health
			 Service Act is amended by inserting after section 409J (42 U.S.C. 284q) the
			 following:</text>
			<quoted-block display-inline="no-display-inline" id="H7849BD838F4E48F39048D51F290FC7B0" style="OLC">
				<section id="H73E4B754C9854407B490F15FB08A865F"><enum>409K.</enum><header>Expansion,
				intensification, and coordination of activities with respect to Tourette
				syndrome</header>
					<subsection id="H8EE614F290C2437FB8B27032DB242336"><enum>(a)</enum><header>In
				general</header><text display-inline="yes-display-inline">The Secretary, acting
				through the Director of NIH, shall expand, intensify, and coordinate the
				programs and activities of the National Institutes of Health with respect to
				Tourette syndrome.</text>
					</subsection><subsection id="H64BA3B87D6F94A3CB8ADF9AE4AA9847A"><enum>(b)</enum><header>Data
				collection</header>
						<paragraph id="HBBF16DFCB1D14935A93D223507A0C3D3"><enum>(1)</enum><header>System</header><text>In
				carrying out subsection (a), the Secretary shall develop a system to collect
				data on Tourette syndrome, including epidemiologic information with respect to
				the incidence and prevalence of Tourette syndrome in the United States.</text>
						</paragraph><paragraph id="H1ED45EE97D3E44539916C3941F7FE805"><enum>(2)</enum><header>Broad and narrow
				definitions</header><text display-inline="yes-display-inline">The data
				collection system under paragraph (1) shall provide for the collection of
				primary data on Tourette syndrome, including related data on the various
				conditions known to be comorbid with Tourette syndrome.</text>
						</paragraph><paragraph id="HC557D2E12A0840EFA082A7AA69F8C3AA"><enum>(3)</enum><header>Collection by
				population and geographical region</header><text>The data collection system
				under paragraph (1) shall provide for the collection of data on the
				availability of medical and social services for individuals with Tourette
				syndrome and their families and the disaggregation of such data by population
				and geographical region.</text>
						</paragraph></subsection><subsection id="H4A8D50F884D24983A5C41083CBB09212"><enum>(c)</enum><header>Centers of
				Excellence</header>
						<paragraph id="HFBA1567E73E14B6CACCFE769F7570A56"><enum>(1)</enum><header>In
				general</header><text>In carrying out subsection (a), the Secretary shall make
				awards of grants and contracts to public or nonprofit private entities to pay
				all or part of the cost of planning, establishing, improving, and providing
				basic operating support for centers of excellence regarding research on
				Tourette syndrome.</text>
						</paragraph><paragraph id="H023C104C81334C9CBBF20D4EF9783EC9"><enum>(2)</enum><header>Research</header><text>Each
				center under paragraph (1) shall conduct basic and clinical research into
				Tourette syndrome. Such research shall include investigations into the cause,
				diagnosis, early detection, prevention, control, and treatment of Tourette
				syndrome. The centers, as a group, shall conduct multidisciplinary research in
				the fields of developmental neurobiology, psychology, genetics, pharmacology,
				psychopharmacology, and neuroimaging.</text>
						</paragraph><paragraph id="H8CEAAA6AD634490AB388438554F22E93"><enum>(3)</enum><header>Services for
				patients</header>
							<subparagraph id="H2635B6C0F12F40AFA15E72C5835DEBE9"><enum>(A)</enum><header>In
				general</header><text>A center under paragraph (1) may expend amounts provided
				under such paragraph to carry out a program to make individuals aware of
				opportunities to participate as subjects in research conducted by the
				centers.</text>
							</subparagraph><subparagraph id="H4AA91CE0C8A146D3BEF0875337FDF60E"><enum>(B)</enum><header>Referral and
				costs</header><text>A program under subparagraph (A) may, in accordance with
				such criteria as the Secretary may establish, provide to the subjects described
				in such subparagraph, referrals for health and other services, and such patient
				care costs as are required for research.</text>
							</subparagraph><subparagraph id="HB7E02174DA334903AC1202F1CCE395D4"><enum>(C)</enum><header>Availability and
				access</header><text>The extent to which a center can demonstrate availability
				and access to clinical services shall be considered by the Secretary in
				decisions about awarding grants to applicants which meet the scientific
				criteria for funding under this section.</text>
							</subparagraph></paragraph><paragraph id="H87E1348B720C472F9817DDEC75F44884"><enum>(4)</enum><header>Organization of
				centers</header>
							<subparagraph id="H85DE1E35A9BA41E79BFD5C58FDDD712F"><enum>(A)</enum><header>In
				general</header><text>A center under paragraph (1) may—</text>
								<clause id="H3D6AA13DAD754CAC8F802A9EF0F48DFA"><enum>(i)</enum><text>use the facilities
				of a single institution; or</text>
								</clause><clause id="H983F0B4B75AC49BC911AD5E5AFE1D9E2"><enum>(ii)</enum><text>be formed from a
				consortium of cooperating institutions and patient advocacy groups in order to
				maximize the scope of the center’s services and geographic coverage.</text>
								</clause></subparagraph><subparagraph id="H8C8CF20366614F818113284543B10982"><enum>(B)</enum><header>Eligibility
				requirements</header><text>To be eligible to make facilities so available (as
				described in subparagraph (A)(i)) or participate in such a consortium (as
				described in subparagraph (B)), an institution or group shall meet such
				requirements as the Secretary may prescribe.</text>
							</subparagraph></paragraph><paragraph id="H768D2A5FD05A4476A75D9C9E62D72AD7"><enum>(5)</enum><header>Number of
				centers; duration of support</header>
							<subparagraph id="HADCB0CCDBDA7493F9F820060FF5D0BD0"><enum>(A)</enum><header>In
				general</header><text>Subject to the availability of appropriations, the
				Secretary shall provide for the establishment of not fewer than 4 and not more
				than 6 centers under paragraph (1).</text>
							</subparagraph><subparagraph id="H2D2FFABA32DE4A82A75F1251CE027E64"><enum>(B)</enum><header>Geographical
				distribution</header><text>The Secretary shall—</text>
								<clause id="H1734226D1CEF46A7BA8444F099FD3D51"><enum>(i)</enum><text>ensure that each
				of the centers established under paragraph (1) is located in a different region
				of the United States than the other such centers; and</text>
								</clause><clause id="H138557E5B2224AE186477A5C3C9F7386"><enum>(ii)</enum><text display-inline="yes-display-inline">encourage the formation of such centers
				from a consortium of entities (as described in paragraph (4)(A)(ii)) covering
				multiple States.</text>
								</clause></subparagraph><subparagraph id="HA5431D3D6D624DDCBE76CDBCC6A1992D"><enum>(C)</enum><header>Duration</header><text>Support
				for a center established under paragraph (1) may be provided under this section
				for a period of not to exceed 5 years. Such period may be extended for one or
				more additional periods not exceeding 5 years if the operations of such center
				have been reviewed by an appropriate technical and scientific peer review group
				established by the Secretary and if such group has recommended to the Secretary
				that such period should be extended.</text>
							</subparagraph></paragraph></subsection><subsection id="H84CE2EB19EF047399098B542BAB91B21"><enum>(d)</enum><header>Research on
				symptomology and treatment</header><text>In carrying out subsection (a), the
				Secretary shall award grants on a competitive basis for research on—</text>
						<paragraph id="H2B495D29D3E9436D8F673DAC0F91D343"><enum>(1)</enum><text>the full range of
				symptomology within the Tourette syndrome clinical spectrum; and</text>
						</paragraph><paragraph id="H14F40C6C1F10443C8647F0D458CE685C"><enum>(2)</enum><text>the efficacy of
				treatment options for particular patient subpopulations.</text>
						</paragraph></subsection><subsection id="HDFC1A09954E8449DAF5300B297DE0C98"><enum>(e)</enum><header>Funding</header><text>Of
				the amounts made available to carry out the programs and activities of the
				National Institutes of Health for a fiscal year, the Secretary shall designate
				a portion of such amounts for carrying out the programs and activities of the
				National Institutes of Health with respect to Tourette
				syndrome.</text>
					</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body>
</bill>
